General Information of the Compound
Compound ID
CP0117181
Compound Name
US9260446, (I-S)
    Show/Hide
Synonyms
XEN-402
    Show/Hide
Structure
Formula
C22H14F3NO5
Molecular Weight
429.35
Canonical SMILES
FC(F)(F)c1ccc(CN2C(=O)[C@@]3(COc4cc5OCOc5cc34)c3ccccc23)o1
    Show/Hide
InChI
InChI=1S/C22H14F3NO5/c23-22(24,25)19-6-5-12(31-19)9-26-15-4-2-1-3-13(15)21(20(26)27)10-28-16-8-18-17(7-14(16)21)29-11-30-18/h1-8H,9-11H2/t21-/m0/s1
    Show/Hide
InChIKey
NEBUOXBYNAHKFV-NRFANRHFSA-N
CAS
1259933-16-8
Physicochemical Property
logP
4.2524
Rotatable Bonds
2
Heavy Atom Count
31
Polar Areas
61.14
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 49836093
SID: 103911771
ChEMBL ID
CHEMBL3707218
DrugBank ID
DB11769
Clinical Information about the Compound
Drug 1 ( XEN-402 )
Drug Name XEN-402
Company Xenon Pharmaceuticals Inc
Indication
Pain
Phase 2
Osteoarthritis
Phase 2
Vasodilatation of extremities
Phase 2
Target(s)
Voltage-gated sodium channel alpha Nav1.7 (SCN9A)
Inhibitor